Keywords
MedicineTau proteinDementiaClinical trialDiseaseTau pathologyNeuroscienceAlzheimer's diseaseOncologyBioinformaticsPathologyPsychologyBiology
Affiliated Institutions
Related Publications
Alzheimer Disease: An Update on Pathobiology and Treatment Strategies
Alzheimer disease (AD) is a heterogeneous disease with a complex pathobiology. The presence of extracellular β-amyloid deposition as neuritic plaques and intracellular acc...
Comprehensive Review on Alzheimer’s Disease: Causes and Treatment
Alzheimer’s disease (AD) is a disorder that causes degeneration of the cells in the brain and it is the main cause of dementia, which is characterized by a decline in thinking a...
Alzheimer disease
Alzheimer disease (AD) is biologically defined by the presence of β-amyloid-containing plaques and tau-containing neurofibrillary tangles. AD is a genetic and sporadic neu...
The Amyloid-β Pathway in Alzheimer’s Disease
Breakthroughs in molecular medicine have positioned the amyloid-β (Aβ) pathway at the center of Alzheimer’s disease (AD) pathophysiology. While the detailed molecular mechanisms...
A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers
Biomarkers have become an essential component of Alzheimer disease (AD) research and because of the pervasiveness of AD pathology in the elderly, the same biomarkers are used in...
Publication Info
- Year
- 2018
- Type
- review
- Volume
- 14
- Issue
- 7
- Pages
- 399-415
- Citations
- 1061
- Access
- Closed
External Links
Social Impact
Altmetric
PlumX Metrics
Social media, news, blog, policy document mentions
Citation Metrics
1061
OpenAlex
Cite This
Erin E. Congdon,
Einar M. Sigurdsson
(2018).
Tau-targeting therapies for Alzheimer disease.
Nature Reviews Neurology
, 14
(7)
, 399-415.
https://doi.org/10.1038/s41582-018-0013-z
Identifiers
- DOI
- 10.1038/s41582-018-0013-z